Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changing Paradigm of Hemophilia Management: Extended Half-Life Factor Concentrates and Gene Therapy

15 Jan 2016

Abstract excerpt

Management of hemophilia has evolved significantly in the last century-from recognition of the causative mechanism in the 1950s to commercially available clotting factor concentrates in the 1960s. Availability of lyophilized concentrates in the 1970s set the stage for home-based therapy, followed by introduction of virally attenuated plasma-derived, and then recombinant factor concentrates in the 1980s and 1990s,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Hemophilia Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26771678
DOI: 10.1055/s-0035-1568877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changing Paradigm of Hemophilia Management: Extended Half-Life Factor Concentrates and Gene TherapyPMID 26771678Read ↗

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and ChallengesSemantic proximity Read ↗

Emerging and future therapies for hemophiliaSemantic proximity Read ↗

Emerging therapies for hemophilia: controversies and unanswered questionsSemantic proximity Read ↗

Recent Advances in the Treatment of Hemophilia: A ReviewSemantic proximity Read ↗

Evolution of the Treatments for Hemophilia.Semantic proximity Read ↗

Recent Advances in Gene Therapy for Hemophilia: Projecting the PerspectivesSemantic proximity Read ↗

The long and short of it: using the new factor products.Semantic proximity Read ↗

Hemophilia A gene therapy: current and next-generation approachesSemantic proximity Read ↗

Hemophilia gene therapy comes of ageSemantic proximity Read ↗

The hope and reality of long‐acting hemophilia productsSemantic proximity Read ↗

Hemophilia gene therapy comes of ageSemantic proximity Read ↗

Gene therapy in hemophilia: the dawn of a new eraSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.